Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2012, Article ID 858073, 9 pages
http://dx.doi.org/10.1155/2012/858073
Research Article

In Vitro Biocompatibility of Endodontic Sealers Incorporating Antibacterial Nanoparticles

1Department of Endodontics, Hebrew University-Hadassah School of Dental Medicine, 91120 Jerusalem, Israel
2Department of Prosthodontics, Hebrew University-Hadassah School of Dental Medicine, 91120 Jerusalem, Israel
3Department of Periodontics, Hebrew University-Hadassah School of Dental Medicine, 91120 Jerusalem, Israel

Received 2 April 2012; Revised 12 June 2012; Accepted 14 June 2012

Academic Editor: Xiaoming Li

Copyright © 2012 Itzhak Abramovitz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The main cause of endodontic disease is bacteria. Disinfection is presently achieved by cleaning the root canal system prior to obturation. Following setting, root canal filling is devoid of any antibacterial effect. Endodontic sealers with antimicrobial properties yet biocompatible may enhance root canal therapy. For this purpose, quaternized polyethylenimine nanoparticles which are antibacterial polymers, biocompatible, nonvolatile, and stable may be used. The aim of the present study was to examine the impact of added QPEI on the cytotoxicity of AH Plus, Epiphany, and GuttaFlow endodontic sealers. The effect of these sealers on the proliferation of RAW 264.7 macrophage and L-929 fibroblast cell lines and on the production of TNFα from macrophages was examined. Cell vitality was evaluated using a colorimetric XTT assay. The presence of cytokines was determined by two-site ELISA. Results show that QPEI at 1% concentration does not impair the basic properties of the examined sealers in both macrophages and fibroblast cell lines. Incorporation of 1% QPEI into the sealers did not impair their biocompatibility. QPEI is a potential clinical candidate to improve antibacterial activity of sealers without increasing cytotoxicity.